Description
Buy Nolvadex Australia
Buy Nolvadex Australia (tamoxifen citrate) is a nonsteroidal antiestrogen used to treat breast cancer that has spread to other parts of the body (metastatic breast cancer), to treat breast cancer in certain patients after surgery and radiation therapy, and to reduce the chances of breast cancer in high-risk patients.
What Are Side Effects of Nolvadex?
Common side effects of Nolvadex include:
- hot flashes,
- flushing,
- changes in menstrual periods,
- nausea,
- leg cramps,
- abdominal cramps,
- bone pain,
- muscle pain,
- cough,
- swelling,
- fatigue,
- hair thinning,
- headache,
- depression, and
- loss of sexual ability/interest (in men).
Tell your doctor if you have unlikely but serious side effects of Nolvadex including:
- vision changes (e.g., blurred vision),
- eye pain,
- easy bruising or bleeding,
- mental/mood changes,
- swelling of ankles or feet, or
- unusual tiredness.
Buy Nolvadex Australia
The recommended daily dose of Nolvadex for patients with breast cancer is 20-40 mg per day, in tablet form.
What Drugs, Substances, or Supplements Interact with Nolvadex?
Nolvadex may interact with coumarin-type anticoagulants, anastrozole, letrozole, rifampin, aminoglutethimide, phenobarbital, rifampin, bromocriptine, SSRI antidepressants, and cimeditdine. Tell your doctor all medications and supplements you use.
Nolvadex During Pregnancy and Breastfeeding
There may be risks to the fetus if Nolvadex is taken by pregnant women, however the benefit of the drug may warrant its use despite the potential risks. Nolvadex has been reported to inhibit lactation. It is not known whether the medication is passed through breast milk, but because of the potential risks for the fetus, women who are taking Nolvadex should not breast feed.
Additional Information
Our Nolvadex Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
Tablets, a nonsteroidal antiestrogen, are for oral administration. NOLVADEX (tamoxifen citrate) Tablets are available as:
10 mg Tablets
Each tablet contains 15.2 mg of tamoxifen citrate which is equivalent to 10 mg of tamoxifen.
20 mg Tablets
Each tablet contains 30.4 mg of tamoxifen citrate which is equivalent to 20 mg of tamoxifen.
Inactive Ingredients: carboxymethylcellulose calcium, magnesium stearate, mannitol and starch.
Chemically, NOLVADEX (tamoxifen citrate) is the trans-isomer of a triphenylethylene derivative. The chemical name is (Z)2-[4-(1,2-diphenyl-1-butenyl) phenoxy]-N, N-dimethylethanamine 2 hydroxy-1,2,3- propanetricarboxylate (1:1). The structural and empirical formulas are:
Uses for Nolvadex
Metastatic Breast Cancer
NOLVADEX (tamoxifen citrate) is effective in the treatment of metastatic breast cancer in women and men. In premenopausal women with metastatic breast cancer, NOLVADEX (tamoxifen citrate) is an alternative to oophorectomy or ovarian irradiation. Available evidence indicates that patients whose tumors are estrogen receptor positive are more likely to benefit from NOLVADEX (tamoxifen citrate) therapy.
Adjuvant Treatment of Breast Cancer
NOLVADEX (tamoxifen citrate) is indicated for the treatment of node-positive breast cancer in women following total mastectomy or segmental mastectomy, axillary dissection, and breast irradiation. In some NOLVADEX (tamoxifen citrate) adjuvant studies, most of the benefit to date has been in the subgroup with four or more positive axillary nodes.
NOLVADEX (tamoxifen citrate) is indicated for the treatment of axillary node-negative breast cancer in women following total mastectomy or segmental mastectomy, axillary dissection, and breast irradiation.
The estrogen and progesterone receptor values may help to predict whether adjuvant NOLVADEX (tamoxifen citrate) therapy is likely to be beneficial.
NOLVADEX (tamoxifen citrate) reduces the occurrence of contralateral breast cancer in patients receiving adjuvant NOLVADEX (tamoxifen citrate) therapy for breast cancer.
Ductal Carcinoma in Situ (DCIS)
In women with DCIS, following breast surgery and radiation, NOLVADEX (tamoxifen citrate) is indicated to reduce the risk of invasive breast cancer (see BOXED WARNING at the beginning of the label). The decision regarding therapy with NOLVADEX (tamoxifen citrate) for the reduction in breast cancer incidence should be based upon an individual assessment of the benefits and risks of NOLVADEX (tamoxifen citrate) therapy.
Current data from clinical trials support five years of adjuvant NOLVADEX (tamoxifen citrate) therapy for patients with breast cancer.
Reviews
There are no reviews yet.